Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):176–182. doi: 10.1097/QAI.0b013e3181ff9750

Table 2.

Odds Ratios and 95% CI for covariates in a multiple logistic random effects model on the reporting of recent UAI with the last or previous partner (n=187 individuals with 228 observations from 195 visits)

95% CI
Variable OR Lower Upper
Baseline Intercept 0.89 0.17 4.68
Follow-up Intercept 0.7 0.15 3.29
Baseline Methamphetamine use** 7.65 1.87 31.3
Follow-up Methamphetamine use** 14.4 2.02 103
Partner HIV uninfected*** 0.14 0.06 0.33
Partner HIV status unknown* 0.33 0.11 0.94
Partner HIV infected (reference) - - -
PAS 1.03 0.98 1.09
Hispanic 2.6 0.86 1.83
Other 0.33 0.06 1.96
White (reference) - - -
Currently taking ARV medication 0.66 0.28 1.54
*

significant at .05,

**

significant at .01,

***

significant at .001

Baseline intercept is an indicator of the initial visit, Follow-up intercept is an indicator of any visit after baseline.